VIRTUAL Program: Tour CRISPR's Innovative HQ in the Seaport!
Presented by the Programs Committee
Presenters:
Denis Desmond, Head of Facilities Services, R&D Operations, EHS Real Estate, CRISPR Therapeutics
Paul Jacobson, Director of Facilities, CRISPR Therapeutics
Event Sponsors:
Tuesday, March 28, 2023 | 5:00pm-8:00pm | Zoom
Join us for an evening presentation and tour of CRISPR Therapeutics’ new Research & Development headquarters, located in Boston, MA. Learn from CRISPR’s Real Estate and Facilities team about how this elegant, state-of-the-art facility maximizes their adaptability to address unpredictable future growth and scientific advances. Presenters will share information about workplace standards, employee engagement, and how they get 50% of their staff into the office every day without a mandate.
We will have an in-person and virtual attendance option, please be sure to select your preferred option with registration. If you are looking to attend in person, please register HERE.
Agenda:
6:00pm: In-person Presentation begins & Virtual Attendees join
7:00pm: In-person tour begins & Virtual Program Ends
Presenter Bios:
Denis Desmond, Head of Facilities Services, R&D Operations, EHS Real Estate, CRISPR Therapeutics
Denis is a Biotech / Pharma business leader with extensive experience in global Facilities & Engineering and Strategic Planning & Program Management. He has extensive expertise in supporting company growth, supporting all areas of the business (R&D, Technical Operations and Commercial) and across a variety of modalities (small molecule, biologics and gene therapy). As Head of Facilities Services, R&D Operations, EHS & Real Estate for CRISPR, Denis provides innovative and strategic leadership for all aspects of CRISPR’s operational infrastructure, including; R&D operations, facilities planning, capital management, engineering, construction, real estate, facilities management, security & EHS.
Paul Jacobson, Director of Facilities, CRISPR Therapeutics
Paul has 16 years of experience as a leader of pharmaceutical capital improvement projects and facility management. As CRISPR’s Director of Facilities, he oversees day-to-day facility operations, as well as how CRISPR’s facilities can support strategic initiatives. Paul interfaces directly with end users to ensure the facility supports their immediate and future needs.